A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours

Recruiting

Phase 1

Phase 2

IPN01194A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours

Sponsor:

Ipsen

Code:

NCT06305247

Conditions

Melanoma

Head and Neck Squamous Cell Carcinoma

Pancreatic Ductal Adenocarcinoma

Colorectal Cancer

Solid Tumor

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

IPN01194

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-02-13. This information was provided to ClinicalTrials.gov by Ipsen on 2026-01-29.